Vision improvement study for advanced AMD
Part of Eyes & vision clinical trials.
This trial tests a new approach to improve vision in people with end-stage age-related macular degeneration (AMD). It aims to help those whose vision has dropped to a moderate or severe level, even with glasses, and who are not contact lens wearers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You have advanced (end-stage) dry or wet age-related macular degeneration (AMD) in at least one eye, confirmed by a full eye exam.
- You have had cataract surgery or do not have a significant cataract in the eye(s) to be treated.
- Your glasses prescription for the treated eye is between -1.50 and +1.50 (a small or moderate correction for distance).
- Your best corrected vision (with glasses) is 20/80 or worse in the better eye and at least 20/400 in the worse eye.
- You do not wear contact lenses, and you have no cornea disease, glaucoma, or prior cornea surgery in the treated eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
This study looks at how the eye’s “central vision” area and connected brain learning/adjustment work in people with advanced macular degeneration. You may be asked to do vision testing using special eye-scanning equipment and follow study procedures that could help researchers better understand the disease.
This trial studies a vision treatment approach for people age 50+ who have dry age-related macular degeneration (AMD) and are legally blind from it. It aims to see whether the treatment can improve vision-related outcomes in the study eye.
This trial studies a vision rehabilitation approach for veterans who have vision loss from age-related macular degeneration. The goal is to see whether the training improves how well people can use vision despite their eye condition.
This study tests new ways to measure vision and take detailed eye images in people with age-related macular degeneration (AMD), a common eye condition affecting central vision. The goal is to develop better tools for future AMD treatment trials.
This trial tests whether visual rehabilitation can help improve both vision and mood in people with advanced dry age-related macular degeneration. It aims to understand the link between vision loss and depression.
Hear when a new Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.